BENEFICIAL OWNERSHIP OF 5% OR MORE

Company

LIGAND PHARMACEUTICALS INC

Filed

December 2, 2005

Accession Number

0001104659-05-058748

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →